RG6561
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 24, 2025
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1 | N=310 | Suspended | Sponsor: Genentech, Inc. | Recruiting ➔ Suspended
Trial suspension • Solid Tumor
August 22, 2024
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1 | N=310 | Recruiting | Sponsor: Genentech, Inc. | Not yet recruiting ➔ Recruiting
Combination therapy • Enrollment open • Metastases • Oncology • Solid Tumor
July 05, 2024
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1 | N=310 | Not yet recruiting | Sponsor: Genentech, Inc.
Combination therapy • Metastases • New P1 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1